Michael F. MacLean

Insider Reports History

Entity
Individual
Location
14 Cambridge Center, Cambridge, MA
Signature
/s/ John B. Moriarty, Jr., J.D., Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael F. MacLean:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Avidity Biosciences, Inc. Chief Financial Officer Common Stock 121K $5.34M $44.00 Sep 19, 2024 Direct
Verve Therapeutics, Inc. Director Stock Option (right to buy) 136K Jun 26, 2024 Direct
Avidity Biosciences, Inc. Chief Financial Officer Stock Option (Right to Buy) 65.2K Jun 12, 2024 Direct

Insider Reports Filed by Michael F. MacLean

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RNA Avidity Biosciences, Inc. Sep 19, 2024 3 -$506K 4 Sep 23, 2024 Chief Financial Officer
VERV Verve Therapeutics, Inc. Jun 26, 2024 1 $0 4 Jun 28, 2024 Director
RNA Avidity Biosciences, Inc. Jun 17, 2024 3 -$439K 4 Jun 20, 2024 Chief Financial Officer
RNA Avidity Biosciences, Inc. Jun 12, 2024 3 -$2.8M 4 Jun 14, 2024 Chief Financial Officer
RNA Avidity Biosciences, Inc. May 14, 2024 3 -$1.46M 4 May 16, 2024 Chief Financial Officer
RNA Avidity Biosciences, Inc. Mar 13, 2024 3 -$628K 4 Mar 15, 2024 Chief Financial Officer
RNA Avidity Biosciences, Inc. Jan 20, 2024 3 -$16.4K 4 Jan 23, 2024 Chief Financial Officer
RNA Avidity Biosciences, Inc. Sep 11, 2023 1 $0 4 Sep 12, 2023 Chief Financial Officer
VERV Verve Therapeutics, Inc. Jun 15, 2023 1 $0 4 Jun 20, 2023 Director
VERV Verve Therapeutics, Inc. Feb 14, 2023 1 $0 4 Feb 16, 2023 Director
RNA Avidity Biosciences, Inc. Jan 20, 2023 2 $0 4 Jan 24, 2023 Chief Financial Officer
VERV Verve Therapeutics, Inc. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
RNA Avidity Biosciences, Inc. Jan 21, 2022 1 $0 4 Mar 15, 2022 Chief Financial Officer
VERV Verve Therapeutics, Inc. Jun 17, 2021 1 $0 4 Jun 21, 2021 Director
VERV Verve Therapeutics, Inc. Jun 16, 2021 0 $0 3 Jun 16, 2021 Director